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Summary.-RNA tumour virus genes are contained in the chromosomal DNA of
most vertebrates, and may be transmitted vertically from parent to progeny along
with other cellular genes, as well as horizontally as infectious particles. Activation
of these viral genes may be part of the means by which RNA tumour viruses produce
cancer. Viral genes and their possible gene products have been characterized. The
envelope glycoprotein, for example, interacts with specific membrane receptors on
cell surfaces and the major phosphoprotein binds to specific viral RNA sequences.
Type-C viral gene sequences have evolved as the species have evolved, and have been
transferred between distantly related species under natural conditions. The presence
of genetically transmitted viral genes in several vertebrate species, including pri-
mates, and the evidence that they may provide normal functions beneficial to the
species carrying them, suggests that the potential to cause cancer is a pathological
manifestation of a normal physiological process.
I PLAN to discuss a group of cancer-
causing viruses that can be considered
either as unusual viruses with a high
propensity to live and replicate as part ofa
cell's genetic machinery or, alternatively,
thought ofas unusual sets of cellular genes
with some capacity to escape from the
host's cell genome. When they escape they
are then able to reinsert themselves in
other parts of the same cellular DNA, in
other cells of the body, in other animals of
the same species, or even in other species.
Examples of each of these situations have
been described. These genes would then be
transmitted from parent to offspring in the
same way as genes that, for example, code
for eye colour or level ofinsulin production
but would, nevertheless, have the unusual
capacity to come out, transfer themselves
and perhaps transfer other cellular genes
to new cells and to new species.
In Table I, I have listed the major
postulated causes of cancer. As you will
note there are both exogenous and endo-
genous causes. The exogenous causes
include radiation, various chemical car-
cinogens and infectious viruses such as the
feline leukaemia virus (Hardy et al., 1973)
and the bovine leukaemia virus (Olson et
al., 1972). There is now clear evidence that
these viruses are transmitted from animal
to animal and that they cause disease as
agents acquired from the outside environ-
ment. On the other hand, there are
various endogenous causes that have been
proposed. One of the aetiological factors
that has to be considered is the group of
RNA tumour viruses. In this context, the
genetically transmitted viruses may play
a role in cancer causation as a result of
activation by exogenous agents, like
radiation and chemical carcinogens; this
can lead to tumour development in the
animal that harbours these viruses and
maintains them as genetically transmitted
elements (Huebner and Todaro, 1969). We
then have to consider the RNA tumour
viruses in two separate categories: one as
infectious agents acquired from the out-
side, the other as genetically transmitted
* This paper formed the Walter Hubert Lectuire delivere(1 at the Annual General Meeting of the British
Associationi of Cancer Reseaich, March 1977.
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TABLE I. Major Postulated Ca8ses of
Cancer
Exogenouw
1. Radiation (various sources)
2. Chemical carcinogens anrl/or mutagens
3. Viruises (horizontally spread, suich as cat leuikae-
mia)
Endogenous
1.
2.
3.
4.
5.
Inheritance of defective and/or permissive genes
that confer susceptibility
Deficient and overactive immunological mechan-
isms
Hormonal disfunctions
The "natural" ageing process
RNA tumour viruses activation of genetically
transmitted virogenes and/or oncogenes
agents that may be activated by a variety
of factors, both external and internal. In
animal systems there are precedents for
tumour production by RNA viruses in
both situations: feline leukaemia virus,
avian myeloblastosis virus, lymphomato-
sis ofchicken, and bovine leukaemia are all
examples of infectious RNA tumour
viruses that are the major causes of
leukaemias and lymphomas in those
species. On the other hand, the inbred
mouse presents a clear model of endogen-
ous viruses becoming activated and
causing cancer in the very same animal in
which the viruses reside. One way of
thinking about this is to ask the question,
"What would happen if human beings
were raised from birth in complete isola-
tion, where they would not be exposed to
any exogenous biological agents such as
viruses? What effect would it have on the
incidence of tumours?" We know from
cat, chicken, and bovine epidemiological
studies that they develop tumours that
could, if there were felt to be sufficient
need, virtually be eliminated as public
health problems, because they behave as
classical infectious diseases. Domestic cats
raised in isolation have, as far as I know,
never developed the typical feline leukae-
mia disease nor have they become infected
with feline leukaemia virus. In the labora-
tory mouse, on the other hand, the
incidence of tumours is essentially un-
changed with animals raised in isolation,
as compared to those raised in contact with
virus-infected, leukaemic mice. What the
results would be in man is not known; the
animal models give us approaches but do
not give us the answer, because both kinds
of transmission of RNA tumour viruses
can be shown to occur andto cause cancers.
Type C particles are assembled in the
cytoplasm and bud from the cell mem-
brane. The nucleus contains the viral
RNA, an enzyme called reverse trans-
criptase, and the major structural proteins
of the virion. In addition, envelope
proteins that are coded for by the virus are
inserted into the cell membrane as the
virus comes out ofthe cells. In some cases,
the extracellular virus can infect other
cells; in other cases, the particle cannot
infect other cells. Endogenous viruses,
then, can be considered a specialized
class of cellular secretory products.
The genes of the RNA tumour viruses,
as suggested by Baltimore (1974) have
been characterized as follows: the gag
gene, whose product is reverse transcrip-
tase and whose action is to make DNA
from viral RNA; the env gene whose
product is the major glycoprotein called
gp7O and whose action is to bind to
specific membrane receptors as an essen-
tial early event in viral infection. Mouse
cells, for example, have high levels of
receptors for the mouse leukaemia viruses
(De Larco and Todaro, 1976). Related
species like the rat have lower levels of
receptors, and more distantly related
species have no receptors at all. The gag
gene codes for a variety of structural
proteins; in the mouse viruses these
include p15, p30, p12, and plO. p12 is a
very interesting protein because it is a
phosphoprotein that will bind specifically
to viral RNA. It will only bind to its own
homologous viral RNA or the RNA of a
very closely related virus (Sen, Sherr and
Todaro, 1976). For example, mouse leu-
kaemia virus p12 will bind to mouse
leukaemia virus RNA and, conversely,
feline leukaemia virus p12 will bind only to
cat leukaemia virus RNA. Thus, this is
another viral gene product that has
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specificity in its action. This specificity
appears to depend on its ability to bind
to specific nucleic acid sequences. The
genes pol, env and gag are all essential
for viral replication. The gene product of
the fourth gene, called onc or sarc, is not
known; it is a growth stimulator and will
transform normal cells into tumour cells.
If this is done in cell culture, the resulting
transformed cells will often produce tu-
mours when inoculated into susceptible
animals. On the other hand, cells can be
transformed by RNA tumour viruses and
have the transformed gene products
synthesized, even though whole virus is
not formed. Later in this presentation I
will suggest some possibilities for the saro
or onc gene products. The suggestion is
that they might be normal growth-
stimulatory factors that cells possess,
which have some functional role during
differentiation and development of the
organism.
Fig. 1 shows 1251-labelled murine gp71
binding to cells growing in tissue culture.
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FIG. 1.-1251-labelled murine gp7l binding to
cells growing in tissue culture.
One sees a high degree ofbinding to mouse
cells, a low degree of binding to species
distantly related to the mouse, and
essentially no binding to cells that the
murine virus cannot infect. There is also a
low degree of binding to cells that either
have been previously infected by mouse
leukaemia virus or have spontaneously
turned on and are producing their own
endogenous mouse leukaemia virus. In
these situations, endogenous production
ofgp7O by the cells results in the covering
up ofthe receptor sites and the inability of
exogenously added labelled gp7O to bind to
cell membranes. These are tissue culture
studies. In studies from the whole animal,
however, it is noted that bone marrow and
thymus cells, in particular, have high
numbers of receptors for the purified
gp7O (De Larco, Rapp and Todaro, 1978).
In contrast, other tissues such as
liver parenchyma have very little or no
detectable receptors. The results of these
studies, using the purified env gene
product and cells taken directly from the
animal, would suggest that an essential but
not sufficient event for leukaemia produc-
tion in the animal is the presence of
specific receptors for the envelope glyco-
protein of the mouse leukaemia virus on
certain target cells in the body. A cell can
greatly reduce its chance of being infected
either by having no receptors or keeping
those receptors covered by producing its
own viral glycoprotein from its own
cellular virogenes. Chicken cells in culture
can be shown to be resistant to infection
by avian sarcoma viruses if they make an
env gene product that blocks the receptors
(Weiss, 1976).
TABLE II. The Specific RNA-binding
Protein ofType-C Viruses
1. Closely associated with the viral RNA in the
intact particle
2. Binds specifically to homologous viral RNA in
vitro
3. The major phosphoprotein in the virus:
Mouse, other rodent origin p12
Primate origin, also RDI 14 p' 6
Avian origin p19
4. Coding site at the 5' end of the viral genome;
some binding sites at the 3' end
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In Table II, I list the particular
properties of the RNA-binding protein of
type-C viruses. It is closely associated
with the viral RNA in the intact genome,
and it binds specifically to homologous
viral RNA in vitro (Sen et al., 1976). The
major phosphoprotein of the mouse virus
and other viruses of rodent origin has a
mol. wt of 12,000. Those of primate
origin, like the baboon virus, have a mol.
wt of 16,000 (Todaro, Sherr and
Benveniste, 1976a; Sherr et al., 1976).
Those of avian origin have a mol. wt
of -A19,000 (Sen and Todaro, 1977). The
coding site for making this protein is at
the 5' end of the genome (Eisenman, Vogt
and Diggelman, 1]974; Vogt, Eisenman
and Diggelman, 1975) and some, but not
all, of the binding sites reside close to the
3' end ofthe genome (unpublished results).
This protein may function in the integra-
tion of the virus genome when it infects a
cell from the outside. The pol gene is
needed to make the reverse transcriptase
which is necessary for the synthesis of
DNA copies of the viral RNA. The
circular DNA then integrates into the host
cell DNA; a gag gene product, perhaps the
phosphoprotein, may play a role in this
process. Once integrated the virus may or
may not express its RNA, its proteins, or
make whole infectious virus again.
TABLE III.-Properties of Endogenous
Type-C Virogenes
1. In the DNA ofall somatic and germ cells ofall the
animals of a species
2. Multiple relate(d but not identical copies present
3. Virus expression (RNA envelope anitigen, poly-
merase, complete particles) iunider cellular
control, expresse(l (luring (levelop)ment 4. Cells of a species are genierally resistant to infec-
tion wNith their own en(logenious viruses
5. Clonal lines ofsome species are capable ofreleasing
complete viruses
Table III lists what I consider to be the
major properties of endogenous type-C
viruses. They are genetically transmitted
and are present in the DNA of all somatic
and all germ cells of all the members of a
species. In fact, they are present in
multiple copies, generally from 10 to 50
copies per haploid genome (Benveniste
and Todaro, 1974a). They are present in
more copies, for example, than are the
genes that code for haemoglobin. Viral
expression is under cellular control; in
some species expression in various tissues
can involve something less than the
whole genome. For example, they
may express only the polymerase, only
the envelope protein or only gag gene
products. These genes are under cellular
control, in the sense that during embryonic
life some of the genes seem to be activated
and expressed for a short time and are
then turned off again. Mouse embryonic
liver and spleen, for example, are positive
for a while for at least some gag gene
products, and then become negative again.
In the male, the cells of the epididymis
become loaded with envelope gp7O in
embryonic life and then turn the ability to
produce this glycoprotein offagain (Lerner
et al., 1976). It appears, then, that the
animal has ways of controlling the expres-
sion of its endogenous viral information.
In general, the endogenous virus of one
species does not grow well in that species
although it may grow quite well in other
species. For example, the endogenous
type-C virus of baboons will replicate well
in dog or mink or even human cells, while
it will replicate only very poorly in other
baboon cells. As the result of a long
association between the genetically trans-
mitted virus and its host it would appear
that mechanisms have developed to pre-
vent the untoward spread of infectious,
exogenous virus throughout the popula-
tion.
Some of the species in which complete
virogene copies have been shown in normal
cellular DNA are listed in Table IV. The
table is incomplete, as additional examples
continue to be uncovered. In addition, a
variety of species have been found where
whole viruses have not been isolated but
the gene sequences can be found in the
cellular DNA; in some of these cases, the
viral information can also be shown to be
expressed as RNA and as certain of the
viral gene products. This appears to be
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TABLE IV.-Species in Wrhich at Least One
Complete Virogene is Known to be
Present in Normal Cells
Chicken Babooni
Chinese hamster (P. papio)
Syrian hamster (P. cyflocep1h(ilos)
Mouse Deer
(M. rnusculus) Mink
(M. caroli) Geladia
(Mll. cervicolor) Langur
Rat Guinea-pig
Cat
Pig
especially true of primates and will be
discussed in more detail later.
Examples of infectious, transmissible
type-C viruses, where the genome is not
found, or at least complete copies of the
genome are not found, in normal tissues of
the species, also exist. The two best
studied examples are probably cat leu-
kaemia virus and bovine lymphosarcoma
virus. Both spread through populations,
infecting considerably more animals than
actually come down with disease. They are
each the major cause ofnaturallyoccurring
neoplasia in the species they infect. To
make clear the point that I am trying to
HORIZONTAL
infectious virus
RNAgeriome
Vor e _ subgroups A&B
trdrisierit viremnia
iMMLJrlity
leukaemia rare
VERTICAL
CONGENITAL 9 GENETIC
INFECTION " TRANSMISSION
irnfectious virus viral DNA genorie
RNA georome integrated \
subgroups A& B gamete DNA
subgroup E
chroric viremia USbldliy leatCrt tolerarnce rio viren
leukaenria crmmort no letokaecria
Fic. 2. Modes of transmissoio iOf aviaI lIeico)siS
virus. (From Tooze, 1973.)
emphasize, I have included a figure (Fig.
2; Tooze, 1973), pointing out that in the
chicken there is horizontal infection where
virus goes from one animal to another and
also two very different types of vertical
infection. In one case, in congenital
infection, the mother is infected and
passes the virus on to the offspring, where
it may replicate and produce disease. The
other kind of vertical transmission is the
kind I have been emphasizing the strictly
vertical transmission where the genes are
part of the egg, part of the sperm and are
transmitted strictly as genetic elements.
Congenital infection in the first case, then,
is more like horizontal transmission,
where new viral information is acquired
from the outside.
I will discuss the genetically transmitted
virogenes of the Old World monkey, the
baboon, in somewhat more detail. Baboons
range throughout Africa and are somewhat
different from one another depending on
their geographic location. Baboons, among
primates, are very unusual in that they
have a very high propensity to release
their endogenous type-C viruses (Todaro
et al., 1976a). Viruses can be isolated from
a variety of tissues of baboons, including
kidney, spleen, placenta and lymph nodes
(Todaro et al., 1976a). The virus can be
isolated from a variety of baboon species,
both from cell cultures and tissue speci-
ments directly (Todaro et al., 1974). The
first baboon type-C viruses isolated were
from cell cultures transformed by feline
sarcoma virus (Todaro, Tevethia and
Melnick, 1973). The addition of agents
such as the halogenated pyrimidines,
BUdR and IUdR, enhance the probability
ofrelease ofvirus, but do not appear to be
essential for virus recovery. The endogen-
ous genetically transmitted virus of each
baboon species is distinct enough so that
DNA transcripts prepared using reverse
transcriptase to copy the viral RNA have
made it possible to determine the species
of origin of different baboon viruses. For
example, viruses from Papio cynocephalus,
an East African baboon, can be readily
distinguished from viruses isolated from
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Papio papio, from West Africa (Todaro
et al., 1976a). The species most distantly
related to the baboon from which virus
has been isolated is Theropithecus gelada.
So far among the higher primates, the
baboons are the only ones that have
released complete type-C viruses; they do
it with a very high probability. The viral
genetic information can be found in the
cellular DNA in multiple copies in all
normal tissues, somatic cells as well as
I--,
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E
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germ cells, from all baboons tested. It cani
also be found in the DNA of baboon cell
lines in culture. Since baboons could be
shown to have this viral information in
their cellular DNA, it was possible to ask
whether related gene sequences are present
in related species.
The Old World monkeys, of which the
baboon is a member, separated from the
higher apes and man roughly 30-45 million
years ago. Before that time, there existed
ATmR (°C) CELLULAR DNA
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FIG. 3.-Evolutionary relationships among primates based on a comparison of cellular gene
sequences and type-C viral gene sequences.
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a common ancestor that eventually would
give rise to man, apes and various species
of Old World monkeys. Further back in
evolution, there was a common ancestor
for the New World, or South American,
monkeys and the Old World monkeys and
apes. While there is some disagreement
about the actual times of divergence,
there is close agreement between fossil and
molecular studies on the relative relation-
ships between these primates.
Using DNA transcripts of the baboon
type-C viral RNA, sequences related to the
baboon virus are found, not only in baboon
cellular DNA, but also in the cellular DNA
of all other Old World monkeys (Benven-
iste and Todaro, 1 974b). The pattern is
what one would expect from an evolution-
ary divergence of these gene sequences
from the viral gene sequences present in
the baboon. Close relatives of the baboon,
such as the mangabey, have closely related
viral gene sequences, while more distant
relatives, like the colobus monkey, have
more distantly related sequences (Benven-
iste and Todaro, 1976). When the genetic
distance of a primate from baboons based
on overall cellular DNA sequences is
compared with the genetic distance of the
particular set of sequences we are interes-
ted in (the type-C viral sequences), it
becomes clear that two different factors
determine this relationship. The first is the
phylogenetic distance from the baboon,
and the second is whether the animals
evolved in Africa or outside Africa. As is
shown in Fig. 3, all the African primates
have viral gene sequences that fall on a
line expected from their evolutionary
distance from the baboon. Similarly, the
Asian primates have sequences that be-
come more distantly related as the last
common ancestor becomes more distant;
however, the Asian primates have viral
DNA sequences that are considerably
more distant from the baboon than the
sequences found in their African counter-
parts. So there is an environmental effect
on the rate at which the Asian and African
virogene sequences have diverged from the
baboon viral sequences, with the Asian
primates, that presumably have had no
contact with baboons for several million
years, showing a more rapid divergence.
Of the primates that we have studied, the
only one whose geographic origin is in
doubt is man. From the viral gene data it
would appear that man behaves like a
Eurasian primate, and not like an African
primate. This would lead us to conclude
that most of man's evolution since diverg-
ence from his Pongid ancestors has
occurred outside of Africa (Benveniste
and Todaro, 1976). This venture into
anthropology may appear somewhat pre-
sumptuous for virologists. As a conse-
quence, the results are still greeted with a
certain scepticism by those who have used
more traditional approaches to the asking
of questions about man's ancestry. How-
TABLE V.-Frequency of Type-C Virus Isolationfrom Normal
Primate Tissues
Tissues Virus 0
Species tested isolates positive
Old ltorld monkeqs
Baboon 12 8 67
Gelada 7 3 4:3
Mangabey 2 0 0
Macaque 51 0 0
Vervet 12 0 0
Apes
Gibbon 41 3* 7*
Chimpanzee 14 0 0
Man 136 0 0
New lI orld moiikeys 1:3 0 0
Total: 288 14 5
* Rodent-like.
14516. J. TODARO
ever, the differences we find are quite large,
and the more extensively we analyse the
viral gene sequences the clearer it becomes
that the viral genes in Homo sapiens are
quite different from the viral genes in his
two closest African relatives, the gorilla
and the chimpanzee. We will speculate
later as to why these differences may have
developed. Support for our thesis on the
location of man's evolution outside Africa
is obtained from the more traditional
palaeontological approaches with fossils of
Ramapithecus, a presumed ancestor of
man, recently uncovered in Hungary,
Turkey, Pakistan and China.
In Table V I have summarized our
experience in trying to isolate reverse-
transcriptase-containing viruses from
primate tissues. One of the things that is
obvious by looking at the number of
attempts we have made is that viruses of
this kind are very difficult to isolate from
human tissues. WVe have looked at normal
as well as tumour tissues, and at embry-
onic as well as agedI human cells. Type-C
viruses like the ones that I have described
above have been isolated from baboon
tissues with great regularity, and from the
closely related genus, Theropithecus, but
cannot be isolated from other Old WA'orld
monkeys (Todaro et al., 1976a).
A type-D virus which has many proper-
ties similar to the type-C viruses but which
may in fact be more closely related to the
mammary-tumour virus of the mouse can
be isolated from one species (Presbytis
obscurus) of the leaf-eating subfamily of
Old World monkeys called Colobinae
(Todaro et al., 1978). This virus is also
an endogenous virus of Old World mon-
keys and, like the type-C virus of the
baboon, is present in multiple copies in the
cellular DNA (Benveniste and Todaro,
1977).
The other group from which type-C
viruses are readily isolated is the gibbons
(Kawakami et al., 1972; Kawakami and
Buckley, 1974; Todaro et al., 1975). In this
case, however, the DNA transcripts of
gibbon virus show that it does not hybrid-
ize to gibbon or any other primate cell
DNA, but rather hybridizes extensively to
various species of rodent cellular DNA, in
particular to mouse (Mus) species such as
the common laboratory mouse (Benveniste
and Todaro, 1973). This virus, then, would
appear to have once been endogenous, and
genetically transmitted in certain rodent
species, and to have been acquired by
primates as a result of infection. Whether
this was direct infection from the rodents,
or whether there were a number of inter-
mediate hosts involved in the process has
not yet been resolved. However, it is
important to point out that this virus now
spreads in gibbon populations and causes
acute myelogenous leukaemia, lympho-
sarcomas (Kawakami and Buckley, 1974)
and in one case an isolate from a woolly
monkey has been obtained that causes
fibrosarcomas (Theilen et al., 1971; Wolfe
et al., 1971). So this group of type-C
viruses clearly is pathogenic and tumour-
producing in primates; they seem to have
been acquired by cross-species infection
from an endogenous virus that resides in
the genetic material of a quite different,
distantlyrelated mammalianorder. Among
the New World primates, the squirrel
monkey stands out as unusual in having a
virus that is readily released from normal
tissues and from cells in culture (Heberling
et al., 1977) and can be shown to be an
endogenous virus in these primates
(Colcher et al., 1977).
The main variable, then, in whether
or not a reverse-transcriptase-containing
virus can be isolated from primate tissues
seems to be the species of origin rather
than the tissue type or whether one starts
with tumour cells or normal cells. Baboons
seem to be unusual in readily releasing
endogenous type-C viruses. Similarly,
squirrel monkeys seem to be unusual
among South American monkeys in the
readiness with which they release their
endogenous viruses.
Thegreatmajority ofthe primate species
do not appear to have whole infectious
viruses. The inability to recover type-C
viruses from most primate tissues may
reflect defects in the viruses, in the virolo-
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gists or in both. It is quite possible that
we are doing something wrong in our
attempts to isolate or activate these
viruses directly from human tissues. The
nucleic-acid-hybridization studies show
that humans do have viral gene sequences
distantly related to the baboon viruses
(Benveniste and Todaro, 1976). Thespecies
more closely related to the baboon, how-
ever, not only have related cellular DNA,
but also make viral-specific RNA and
certain viral-specific proteins (Sherr,
Benveniste and Todaro, 1974; Todaro et
al., 1974; Aaronson and Stephenson, 1976).
So the genes in those species are not
repressed, and the reason complete virus
is not made is not fully understood. It may
be that the genes for making a whole virus
in most species are no longer physically
linked to one another as they are in
the virus, and thus are not in a form that
allows, them to be readily packaged as a
discrete entity. It depends on what one
considers to have been the selective
pressure conserving these sequences; is it
the ability to make the whole virus that is
conserved, orisittheindividualgenessuch
as those coding for the DNA polymerase,
the envelope antigen and a specific RNA-
binding protein that are conserved? Ifit is
the individual genes that have been
selected for, there may be no particular
reason why they have to be activated
together or even be localized on the same
chromosome. If they are now scattered
around the genome, they could still func-
tion individually, but the probability of
making a whole virus would be extremely
low.
Fig. 4 shows the morphological differ-
ences between the type-C viruses from
gibbons and type-D viruses that have been
... iMOT rv
SIG. 4.-Morphological differences between type-C viruses from gibbons and type-D viruses from
langurs.
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TABLE VI. Evidence for Origin of Gibbon
Virus Groupfrom a Rodent (Mus species)
TABLE VII. Species of Felis Tested for
Endogenous Type-C Virogenes
1.
2.
Gibbon viruses hybridize to rodlent (Mus)
cellular DNA an(d not to primate DNA
Gibbon viral proteins (p30, reverse transcriptase)
are closely relatedI antigenically to same
proteins isolatedl from Asian 2luos species (M.
ccaroli, M. cer?icolor)
In early 1973, a virus called RD-114
(McAllister et at., 1972) that had been
isolated from a human tumour inoculated
into embryonic cats, was considered to be
either a new cat or human type-C virus. It
was subsequently shown to be a new cat
virus that was endogenous and genetically
transmitted in cats (Livingston and
Todaro, 1973; Fischinger et al., 1973). This
virus is very similar in its antigenic
properties, and by molecular hybridiza-
tion, to the baboon endogenous viruses
that our laboratory first isolated from
baboon cell cultures (Todaro et al., 1973;
1974). The only way it became possible to
explain this relationship was to suggest
that an ancestor of the domestic cat
actually acquired a virus from primates
and that this virus somehow got into the
germ cells of the ancestors of the domestic
cat, setting up residence so that now all
domestic cats have this virus. Related
species of the genus Felis, which includes
the domestic cat, also havethesesequences,
but only those cats from North Africa and
the Middle East, and not the species
that have lived in Asia or North or
South America. So the virus seems to be
acquired only by those cats that have had
contact with African primates, most
probably with baboons or one oftheir close
relatives (see Table VII).
There exist several other examples of
the transmission of viral genetic material
between different species, and these are
summarized in Table VIII. The data on
genetic transmission is most clearly estab-
lished with the primate endogenous viruses
and with the various rodent endogenous
viruses. In addition to the cat virus
(RD-114 group) that was acquired from
primates, we have reported that the other
type-C virus ofcats, feline leukaemiavirtus,
Tested-positive
Domestic cat
(Felis catus)
Juinigle cat
(Felis ch(tus)
European wildcat
(Felis s8ylestris)
Sandl cat
(Fel8s n/oirg(oritot)
Tested-negative
Leopard cat
(Felis beuqgalensis)
Temrnincki's cat
(Felis tem?rninicki)
Fishing cat
(Felis viverrinoa)
Geoffrey's cat
(Felis geojroyi)
Ocelot
(Felis pardlutlis)
North Africa,
Mi(l(lle East
Egypt, India,
South-east Asia
Eturope, Asia Minor
North Africa,
liMiddle East
Inclia, South-east
Asia
South-east Asia
Indlia, South-east
Asia
Souith America
North and South
America
was also acquired, most likely from
ancestors ofthe rat (Benveniste, Sherr and
Todaro, 1975). Domestic pigs, as well as
their wild relatives, including the African
bush pig and wart hog, have acquired a
genetically transmitted virus, again de-
rived from rodent endogenous viruses
(Benveniste and Todaro, 1975). A more
recent example we have uncovered in-
volves mink virogene sequences present in
mink, ferret and weasel cellular DNA that
also appears to have some homology with
rodent type-C viruses (Sherr, Benveniste
and Todaro, 1978). The point, then,
is that viral genes can be incorpora-
ted into the genetic information of a
distantly related species, can be success-
fully conserved in the new host and
become part of a new portion of the
information of the recipient species. Ob-
viously we cannot recognize the examples
where the virus was deleterious to the
recipient, or did not get into the germ
cells. Thus this movement of genes
between species mediated by this family of
viruses may be much more common than
we now suspect and may be part of the
natural process by which species maintain
contact with one another. Movements of
genes from one species to another, then, is
not some recent event that molecular
biologists have createdl in the laboratory,
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TABLE VIII.- Examples of Transmission of Type-C Viral Genes Between Species
Donor
1. Primate (Old World monkey)
2. Rodent (mouse ancestor)
3. Rodent (rat ancestor)
4. Rodent (unknown ancestor)
5. Rodent (Mus caroli, Mus cervi-
color or close relative)
Recipient
Felis (anicestor ofthe dlomestic cat)
Pig anicestor
Felis (ancestor ofthe dlomestic cat)
M1ustele (mink.-weasel-ferret
ancestor
Primates (gibboins, possibly
humans)
Genietically transmittedl in
recipient
Yes
Yes
Yes (but also horizontally
trainsmittedl in Felis cotus
poptilations)
Yes
No
but rather is part of a process that has
been going on in vertebrates over a long
period of time. The type-C viruses I have
described are ideally suited for this role,
because they integrate into cellular DNA
and generally do not kill the cells they
infect.
I would like to switch now and talk
about the sarcoma viruses and the gene
called sarc or onc. When a type-C virus
infects a cell there are three possible
outcomes, as indicated in Fig. 6. The virus
can transform the cell it infects and
produce new virus progeny. It can trans-
form the cell but not produce new virus,
thus generating "non-producer, virus-
transformed cells". It also can infect the
cell, producing new virus but not causing
any morphological changes in the cells.
The great majority ofnatural virus isolates
are non-transforming or weakly transform-
ing. However, some virus isolates from
chicken, mouse and rat, and one woolly
monkey virus isolate, rapidly transform
cells in tissue culture from a normal to a
tumorigenic state. All of these also readily
produce sarcomas and other solid tumours
when inoculated into susceptible animal
hosts.
When cats are exposed, either naturally
or experimentally, to feline leukaemia or
feline sarcoma viruses, they make anti-
bodies to the structural proteins of the
virus. They also make antibodies to a new
virus-induced cell-membrane antigen (or
antigens) called FOCMA (feline oncorna-
virus cell membrane antigen) (Essex et al.,
1971a, b). Various epidemiological studies
have shown that it is the ability of aIn
animal to make FOCMA antibody success-
fully that is the single most important
determinant of the outcome of infection
with the tumour virus. Cats that respond
well to this new antigen successfully
resist their tumour and, in fact, are
resistant to challenge by the same virus or
by virus-induced tumour cells (Essex et al.,
1975a, b; 1976). The FOCMA antigen that
is present in the cell membrane does not
appear to be identical to any of the known
viral structural proteins, at least in the
form that we know them in the virus
particle. A few years ago we found that we
could transform mink cells using feline
transformed
not producing virus
non-transformed,
producing virus
Fi(.. 6. Schematic rel)resentation of the
possible results of the infection of fibro-
blasts bytype-Cviruses. (Fro)mTooze, 197:3.)
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sarcoma virus, and made several non-
producerfeline-sarcoma-virus-transformed
mink cells (Henderson, Lieber and Todaro,
1974). When these cells are tested with
FOCMA antibody, they give very strong
positive reactions; in contrast, cells trans-
formed by mouse or rat sarcoma virus do
not have the FOCMA antigen (Sliski et al.,
1977). Cells infected with just the helper
leukaemia virus also lack this antigen. The
antigen, then, is specific for feline-sarcoma-
virus-transformed cells and not for virus
infection per se (Sliski et al., 1977). Under
natural conditions the ability to produce
FOCMA is the major factor in determining
whether or not an animal will successfully
resist its tumours. The non-producer
transformed mink cells allow an opportun-
ity to purify this specific antigen. The
experiments show, further, that the anti-
gen is coded for by the feline sarcoma
virus: the antigen in the cell membrane
could conceivably be a sarcoma gene
product, or reflect some change in the cell
membrane induced by the sarcoma gene
product. Alternatively, it could represent
an unusual form of one of the virus
structural proteins.
When one considers whatisknown about
the characteristics of the sarcoma gene, or
the oncogene, additional properties be-
come apparent. The first is that the gene is
closely related, if not identical to, genes
present in normal cellular DNA. This has
been shown bystudies ofthe sarcoma-gene-
specific nucleic acid sequences and their
ability to hybridize to various cellular
DNAs (Stehelin et al., 1976; Frankel and
Fischinger, 1977). The second is that it is
well conserved in evolution as demonstra-
ted by studies using specific probes to the
sarcoma-gene portion of the virus; related
species have related gene sequences
(Stehelin et al., 1976; Frankel and Fisch-
inger, 1977). In fact, the sarcoma-gene
portion seems to be more highly conserved
than the viral-gene portions of the type-C
genome. Deletion mutants of chicken
sarcoma viruses exist that have lost their
ability to transform cells in culture. On the
basis of the size of the deletion, one would
estimate that the gene or genes involved in
the transformation could not code for a
protein with a mol. wtgreaterthan 50,000-
60,000. It appears to be produced only in
very low quantities in transformed cells be-
cause, to date, attempts to isolate it have
not been successful, while the other viral
gene products are readily detected. Its ac-
tionis tostimulate cellgrowth.The sarcoma
viruses can add this gene from the outside
and cause transformation even in heterolo-
gousspecies. For example, chicken sarcoma
virus will transform mouse, rat and even
human cells in culture, and mouse sarcoma
viruses will transform cells of almost any
vertebrate species. These studies would
suggest that the sarcoma genes that pre-
exist in normal cells may also become
activated by means other than viral
infection from the outside, and when they
are expressed they may be able to produce
an effect on the cells very similar to that
produced when sarcoma genes are added
by viruses from the outside.
What sorts ofthings fit this model? One
class of substances that has to be consid-
ered is those growth hormones that stimu-
late cells to divide, that are present in low
amounts, and that have normal physio-
logical functions in development and
perhaps throughout the entire lifetime of
the animal. An example is a substance
called epidermal growth factor (EGF).
This is a protein with a mol. wt 6,000. It
has 53 amino acids and has been complete-
ly sequenced (Cohen, Carpenter and
Lembach, 1975). When injected into new-
born mice it causes their eyelids to open
earlier, or their tooth buds to erupt
slightly earlier, than in the untreated
animals. Using this assay, Stanley Cohen
was able to purify the substance (Cohen,
1962, 1974). More recently it has been
shown to be a potent stimulator of cell
division in tissue culture, able to induce
resting mouse or human diploid cells to
begin to divide again (Armelin, 1973;
Wrestermark, 1976). It produces its effect
by binding to specific membrane receptors
(Hollenberg and Cuatrecasas, 1975; Car-
penter and Cohen, 1 976). The growth-
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factor-receptor complex then somehow
transmits a signal to the nucleus that leads
to induction of cellular DNA synthesis.
Cells that lack this specific membrane
receptor are unable to be stimulated by
exogenously added EGF. This substance
appears to be highly conserved in evolu-
tion, as mouse EGF and human EGF
cross-react strongly with one another and,
in fact, compete equally well for receptor
sites on the membranes of various mam-
malian cells (Carpenter and Cohen, 1976;
Todaro, De Larco and Cohen, I]976b). A
substance of this kind has most of the
properties one would expect of a sarcoma
gene product. What is the evidence that,
in fact, it should be considered as a candi-
date oncogene product? Recent experi-
ments from our laboratory have suggested
that sarcoma-virus-transformed cells pro-
duce such a substance (see Table IX). We
have, over the years, accumulated large
numbers of cell lines transformed by
different agents, starting with the parental
mouse cell called 3T3 (Todaro and Green,
1963) or BALB/3T3 (Aaronson and
Todaro, 1968). These are mouse cells that
have proved useful for studies of cell
transformation, because they are continu-
ous cell lines that grow well but do not
cause tumours when directly inoculated
into animals, and they are very susceptible
to transformation by a wide variety of
agents. They have been transformed by
DNA-containing viruses such as polyoma,
SV40 (Todaro, Habel and Green, 1965)
and herpes simplex virus (Duff and Rapp,
1975) by RNA-containing viruses such as
mouse sarcoma and chicken sarcoma
viruses, and by various chemical agents
TABLE IX. Evidence that Sarcoma-virus-
transformed Cells Produce an EGF-
related Substance
1. Cell extracts compete for EGF-bii(ling sites, not
for gp7O or MSA-birndinlg sites
2. Coincentrate(d supeirinatants will stimulate DNA
synlthesis in serum-dIeprived 3T3 cells
:3. The activity is heat-stable, acid-stable, protease-
sensitive, buit niot precipitated with ainti-EGF
an-tibody
such as methylcholanthrene and dimethyl-
benzanthracene. They can also be trans-
formed by high doses ofradiation (Pollack,
Aaronson and Todaro, 1970). When nor-
mal cells are compared to various trans-
formed cells, it is seen that only mouse-
sarcoma-virus-transformed cells are alter-
ed in their ability to bind exogenously
added 1251-labelled epidermal growth
factor (1251-EGF) (Todaroetal., 1976b).The
mouse-sarcoma-virus (MSV)-transformed
cells cannot bind exogenously added EGF,
while DNA-virus-transformed cells and
most of the chemically transformed cells
bind labelled EGF very well. This is not
the result of virus infection or virus
production, because non-transforming vir-
uses infecting and growing in these cells do
not affect the level of EGF binding. It
then appears to be specific for RNA-
sarcoma-virus-transformed cells and not
transformed cells in general.
Several other factors have been charac-
terized that are also polypeptides with
mol. wts in the range 5-15,000; they, too,
are highly conserved in evolution, interact
with specific membrane receptors, and
induce cells to begin to divide. Another
one that we have studied is a factor called
multiplication-stimulating factor (MSA).
This factor is closely related to the human
somatomedins. It has been isolated and
purified from a rat liver-cell line that
produces this substance (Dulak andTemin,
1973; Temin, Smith and Dulak, 1974;
Nissley and Rechler, in press). MSA, like
EGF, stimulates cell division in 3T3 cells
and various normal human diploid fibro-
blasts and human glial cells. The sar-
coma-virus-transformed cells, that are
greatly altered in having lost EGF
receptors, are unaltered in their levels of
MSA receptors (Todaro et al., 1977).
Similarly, the receptors for the envelope
gene product, gp7O, are unchanged in
transformed as opposed to normal non-
producer cells (Todaro et al., 1976b). The
effect, then, seems to be specific both for
the sarcoma virus and the EGF receptor
system.
In our more recent studies, we have
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attempted to purify an EGF-related
substance from sarcoma-virus-transform-
ed cells. At the moment we have data
indicating that sarcoma-virus extracts do
contain a substance that will compete with
the EGF receptors, but not with the gp70,
MSA or NGF-specific receptors. This
activity is heat-stable, acid-stable, pro-
tease-sensitive and reacts with anti-EGF
antibody. Thus, we think we do have
evidence that sarcoma-virus-transformed
cells produce a substance much like EGF.
Direct attempts to demonstrate that it is
the sarcoma gene product itself are in
progress.
When a variety of human tumour cells
are tested for EGF receptors (Giard et al.,
1973) the great majority ofthem are found
to have normal levels of receptors and, in
many cases, even higher levels than human
diploid fibroblasts (Fabricant, De Larco
and Todaro, 1977) (see Table X). However,
we have come across two human tumour
lines that have no apparentEGFreceptors.
One is a rhabdomyosarcoma (A673) and
another is a bronchogenic carcinoma
(9812). The great majority of human
tumour cells in culture, however, have
EGF receptors. The two that appear to be
lacking EGF receptors are currently being
tested for the possibility that they appear
TABLE X. 1251-EGF Binding to Human
Fibroblasts and to Human Tumour Cells
Normll fibroblasts
Embryonic lung
Newvborn foreskin
Aduilt skin (early passage)
Adult skin (late passage)
Adult skin (SV40 transformed)
Tumour cell lines
Vulva carcinoma A4,31
Pancreatic carcinoma Al 165
Renal-cell carcinoma A498
Epidermoidl carcinoma A388
Bladder carcinoma A1663
Fibrosarcoma 8387
Glioblastoma A172
Rhabdomyosarcoma RD
Rhabdiomyosarcoma A673
Bronchogenic carcinoma 9812
11
125-EGF boundl
(fmol/106 cells)
21
29
24
28
35
203
35
58
67
38
52
22
34
< 0 1
<0]
to lack EGF receptors because they
produce the substance or a related sub-
stance themselves. Two other fibrosarco-
comas lack MSA receptors while having
EGF receptors. In this case, in vivo
transformation may be associated with
perturbation of the MSA-receptor system
rather than the EGF-receptor system
(Todaro et al., 1977). One of the human
fibrosarcomas produces a factor that
competes for the MSA-specific receptors
and stimulates cell division of 3T3,
normal rat and human diploid cells in
culture.
From the above studies, we would
propose a model for cell transformation.
Cell growth in a developing organism is
controlled, in part, by the particular
display of growth-factor receptors on the
surfaces of the cells. Growth factors would
be produced by cells that do not them-
selves respond to them. Thus, inappropri-
ate production of growth factors, unusual
responsiveness to growth factors, or some
alterations in the receptors in recipient
cells could serve as an endogenous stimu-
lus for cell division. Persistent production
of growth factor, or of something that
interacts with the receptors in a manner
like the exogenously added growth factor,
would serve as a continued stimulus for
cell division and inappropriate cell growth.
By this model, the sarcoma virus would
contain growth-factor genes, or genes that
result in the production ofgrowth factors,
or a substance that interacts with the
receptors so as to mimic the effect of the
growth factors.
Another growth factor that may have
considerable clinical interest is a sub-
stance called nerve-growth factor (NGF)
(Levi-Montalcini and Angeletti, 1968).
This has been shown to allow the out-
growth of dorsal-root ganglia (Levi-
Montalcini, Meyer and Hamburger, 1954);
specific membrane receptors have been
found on nerve cells and neuroblastoma
cells (Revoltella et al., 1974). In some
recent studies we have found that human
melanoma cells have particularly high
levels of receptors for NGF. Binding of
153G. J. TODARO
-
x
.E
0
z
D
0 m
(9
z
cq
Cell Number (xO710-)
FIG. 7.--Binding of 125I-labelled nerve growth
factor to melanoma cells (0) compared to
its binindg to sarcoma or carcinoma cells
(A).
NGF to these cells is specific for melanoma
cells; there is no detectable binding to
normal fibroblast or brain cells, or to
sarcomas, carcinomas or lymphoid tum-
ours (Fabricant et al., 1977). So here again
there appears to be a specific marker of a
particular differentiated type. Fig. 7
shows the binding of 1251-labelled NGF to
melanoma cells as compared to its binding
to sarcoma or carcinoma cells. While the
series is not at all large at the moment, it
does appear that metastatic melanoma
has higher levels of receptors than do
primary tumours (Fabricant et al., 1977).
It is hard to determine whether normal
melanocytes also have receptors or this
represents a re-expression of embryonic
antigen. Melanocytes are of neural crest
origin and it may not therefore be surpris-
ing that they bind NGF as readily as they
do.
Some of the potential uses of this dis-
covery are as follows; 1251 or 1311-labelled
NGF may be useful as a scan to localize
melanoma cells in the body, since the cell
types that are known to bind labelled
NGF are centrally located. "Hot spots" of
NGF binding may serve as a useful early
marker for primary or metastatic melano-
mas.
Various laboratories have reported com-
mon melanoma antigens that have ap-
peared to cross-react between tumours
from different patients (Hellstrom, Hell-
str6m and Warner, 1973; Hellstr6m and
Hellstrom, 1973; Hellstrom et al., 1973).
The possibility should be considered that
the common antigen might be the NGF
receptors or the NGF receptors complexed
to NGF. Experiments to test whether the
NGF receptors can be used as a common
antigen and perhaps as a point of attack
for cytotoxic tests should be considered.
If it is, in fact, the case that metastatic
melanomas have higher levels of NGF
receptors than the primary melanomas,
and if NGF serves to stabilize the cells,
thereby increasing their capacity to sur-
vive, NGF itself may play a significant
natural role in determining whether or not
melanomas will successfully metastasize.
If this is the case, one might consider the
possibility of decreasing the chances of
spread with anti-NGF antibody or anti-
NGF-receptor antibody, given perhaps at
the time of removal of the primary tum-
our. Since there are model systems with
mouse melanomas which do have some
NGF receptors, this can be tested. Studies
in the animal may give some clue as to
whether this kind of approach might be
feasible in man.
TABLE XI. Possible Functions of Genetic-
ally Transmitted Virogenes in Normal
Cells
1. Activation of oncogenic information, while in-
appropriate in adult tissue, plays a normal role
during differentiation and dlevelopment
2. The integrated virus serves to protect the species
against related, more virulent infectious type-C
viruses
3. Virus activation, being linked to transformation,
protects the animal by altering the cell mem-
brane. The released virus could alert the
immune system making the transformed cells
more susceptible to immunologic control
4. As conveyors of genetic information between
species they may have had anevolutionary role.
Only this group of viruses have been shown to
transmit genes between germ cells of different
species tin(ler natuiral conditions
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The last table (Table XI) summarizes
what I would think are the major possible
explanations why these virus gene sequ-
ences have persisted so long and so well in
so many vertebrate species. If they had
any significant survival value to the host
species, this advantage might greatly out-
weigh the negative effect that they would
have by occasionally producing tumours
either in their own host or in distant hosts.
The first possibility would be that the
viral gene-oncogene system has some
normal role during embryonic life in
differentiation and development, and per-
haps this involves cell recognition or
specific stimulation of certain types of
cells, as well as the transmission of
information from one cell to another.
Whatever the reason, if this were the case,
the inappropriate expression of viral or
oncogenic information in adult life might
be a minor factor, in an evolutionary
sense, although obviously quite important
to the individual involved, compared to
the selective advantage, in maintaining the
system.
The second kind of system in which it
might be advantageous to the host would
be if the endogenous, genetically trans-
mitted virus served to protect the animal
against related more virulent viruses that
may be acquired from the outside or may
even reside in its own genetic information.
There are numerous examples in bacterial
systems of integrated viruses that protect
the host cells by producing immunity
factors against related viruses. It may well
have been, for example, that the cat
ancestors that came to Africa and came in
contact with the baboon virus were
originally damaged by that virus. Those
cats that were able successfully to inte-
grate the virus might have been at a
selective advantage relative to those that
could not, because it conferred some
protection against infection. Even today
this is demonstrable by the fact that the
baboon type-C virus will not grow in cat
cells, nor will the cat virus grow in baboon
cells, although their host range is quite
wide. The resistance to infection appears
to have persisted. It may be that one ofthe
ways an animal has of protecting itself
against a potentially harmful tumour
virus is to integrate it, making it a part of
its own genes and, as a consequence,
acquiring a certain measure of immunity
to repeated infection by the same or
related viruses. This immunity could be at
the level of blocking the receptors for
entry into the cell, it could be intracellular
at the level of preventing the DNA from
integrating, or if, in fact, there are only a
limited number of integration sites in the
DNA, it could protect by actually occupy-
ing those sites.
The third model is an immunological
one, and takes into account the finding
that transformed cells, or tumour cells in
general, more readily release their endo-
genous virus than do normal cells (Lieber,
Livingston and Todaro, 1973). The activa-
tion ofviral information that results in the
protection of new cell-membrane antigens
might actually be protective to the host,
by calling attention to the cell and
increasing the possibility that the immune
system will reject the newly transformed
cells. Following this line ofreasoning, then,
it might be evolutionarily advantageous
for the viral gene to be linked to the
transforming gene so that, when cells
became transformed, if they expressed
viral antigens they would be more likely
to be handled by a competent immune
system. In a sense, then, cancer would be
"causing" viruses rather than the other
way around.
The fourth, and most speculative,
model is that they have served an import-
ant evolutionary role in the development
of higher organisms by virtue of their
ability to transmit cellular genetic infor-
mation between species. That they can
transmit themselves between species has
been amply documented (see above). That
they can pick up cellular genes has also
been described (Scolnick, Maryak and
Parks, 1974; Shoyab and Baluda, 1975).
That this has been a major evolutionary
force, however, remains only a speculation.
At the point that a species becomes
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distinct enough from all other species that
it can no longer exchange genes, its
ability to change is limited to its ability to
rearrange and duplicate its existing genes;
it no longer has the potential to acquire
genes from geographically close, but
genetically distant, species. The virus
provides one means of keeping species in
contact with one another. The type-C
viruses are admirably suited for this
because they integrate with cellular DNA.
When they come out again, they emerge
with the possibility ofhaving incorporated
cellular genes and transmitting them to
new cells, and to new species. From this
perspective, the fact that they might
occasionally transmit the wrong informa-
tion to the wrong cell or become activated
at the wrong time and in the wrong place
might be a minor price for the species to
have to pay in return for a system that
allows them to sample information from
distant parts of the body as well as from
genetically distant species. The great
majority of genes acquired in this fashion
would be irrelevant or harmful. But if one
in a billion or one in a trillion were useful
to the recipient species, it might be
enoughto have maintainedthesystem. The
selective pressure then would be to
preserve a system that allowsthereceiptof
information from distant species. The
occasional individual that receives the
wrong information would not, in an
evolutionary sense, be of much conse-
quence. Viewed then, from this perspec-
tive, this group of viruses may help us to
understand fundamental questions about
control of cell growth and differentiation,
regulation of expression and evolution.
This fascinating group of viruses and
cellular genes, on balance, would be help-
ful to the species. The occasional produc-
tion of tumours by this group of viruses,
or "escaped" cellular genes, would then be
a pathological manifestation of a perhaps
widespread, normal process. Our increased
understanding of the normal functions of
this system may allow us to deal better
with its pathological manifestations when
we encounter them.
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